Permethrin dusting powder

Safety Data Sheet
NOTE: Access to a copy of this Safety Data Sheet (SDS) via our Website does not constitute the issue of a controlled Copy under EUlegislation. To be issued with such a copy please contact Rentokil Initial at the address below by telephone, fax or in writing. In order toconfirm the latest version of the SDS for this product seclick on Technical Information / Product Safety.
REVISION (see box 16)
27 : 10 : 2005
IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND COMPANY
Product Name
PERMETHRIN DUSTING POWDER
Description
An insecticide for professional use. A light grey-white, free flowing powder.
Rentokil Initial UK Ltd, Pest Control, Felcourt, East Grinstead, West Sussex. RH19 2JY. United Kingdom.
Telephone: +44 (0)1342 833022 Facsimile: +44 (0)1342 326229 HAZARD IDENTIFICATION
Classification (Supply – Use) : In compliance with EC Directive 1999/45.
DANGEROUS
R50/53 Very toxic to aquatic organisms, may cause long term adverse ENVIRONMENT
Adverse Physical, Chemical, Significant Human Health and Environmental Effects (See also box 11):
Irritating and harmful fumes may be evolved in the event of a fire.
High doses may cause repetitive activity in sensory and motor nerves. Early signs of exposure include nausea, vomiting, dyspnoea,hypernoea, tremors, general weakness and prostration. If dust is ingested product may be readily absorbed from the gastrointestinaltract. May cause transient irritation of the eyes, skin and mucous membranes.
No other significant adverse effects expected under normal conditions of handling and use.
COMPOSITION / INFORMATION ON INGREDIENTS (SEE ALSO BOX 16)
Common*/Chemical Name, Elincs/Einecs & CAS No. of Ingredients
EC 1999/45 Classification
Permethrin* / 3-phenoxybenzyl (1RS, 3RS, 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2- EINECS : 258-067-9 N : R50,53 CAS : 52645-53-1 PERMETHRIN DUSTING POWDER
SDS No. 098
Issue : 06
27 : 10 : 2005
Page 1 of 4
FIRST-AID MEASURES (SEE ALSO “ADVERSE EFFECTS” IN BOX 2)
Inhalation
Remove patient to fresh air, keep warm and at rest. Apply supportive measures if necessary and seekmedical attention.
Eye Contact
Rinse affected eye with clean running water, or eyewash solution, for at least 15 minutes holding eyelidswell apart. Rinse entire surface and do not allow run-off to contaminate unaffected eye. Seek medicalattention.
Skin Contact
Remove and wash contaminated clothing immediately. Wash affected area thoroughly with soap andwater. If the patient feels unwell seek medical advice.
Ingestion
Do NOT induce vomiting. If unconscious place in the recovery position and apply supportive measures if (Swallowing)
necessary. If conscious give patient up to ½ litre or 1 pint of water to drink. Seek medical attention.
Emergency
Appropriate first-aid equipment should be provided. For the UK this should be in accordance with the Equipment Suggested Health & Safety (First-Aid) Regulations 1981. See also the Approved Code of Practice “First-aid at
Note To Doctor
Further information on all Rentokil Initial formulations is lodged with the National Poisons InformationService in the UK.
FIRE FIGHTING MEASURES
Fire Extinguisher
Use foam, carbon dioxide, dry powder or water-spray.
Type
Special Fire-Fighting

Wear suitable personal protective equipment and suitable personal protective equipment.
Procedures
Special Exposure

In the event of a fire, harmful and irritating fumes may be evolved.
ACCIDENTAL RELEASE MEASURES
Personal Precautions
Wear suitable personal protective equipment.
(See also box 8)
Environmental

This product is classified as dangerous for the environment. Keep away from drains, surface and ground Precautions
Clean-up Procedure
Gather up spilt material being careful not to create dust clouds and transfer to a suitable container for (See also box 13)
HANDLING AND STORAGE (SEE ALSO BOX 8)
Handling
No specific handling requirements for unopened packs and containers. Avoid dust formation.
Store in original container in a cool, dry, ventilated place out of the reach of children and away from food,drink and animal feeding stuffs.
EXPOSURE CONTROLS/PERSONAL PROTECTION
Exposure Standard -
Workplace Exposure Limit (WEL) for magnesium carbonate is 10 mg/m3 long-term exposure (8 hour Directive EC/98/24 (1St
Time Weighted Average) for total inhalable dust and 4 mg/m3 long-term exposure (8 hour Time Weighted IOELV Directive)
Average) for respirable dust.
Magnesium carbonate is referred to as magnesite in Directive EC/98/24 (1St IOELV Directive).
Engineering Controls
Where exposure may occur, engineering controls, rather than the provision of Personal ProtectiveEquipment (PPE) should be employed. On completion of a risk assessment, the following PPE may berequired: Eye Protection
Suitable eye protection such as goggles.
Hand Protection
Suitable hand protection such as gloves.
Skin Protection
Suitable skin protection such as coveralls.
Breathing Protection
Do not breathe dust. Otherwise wear suitable respiratory protective equipment and eye protection. For theUK, see HSE Guidance Booklet HS(G) 53: “The Selection, Use and Maintenance of Respiratory ProtectiveEquipment – A Practical Guide”.
Environmental
Use only in accordance with instructions given.
Exposure Controls
PHYSICAL AND CHEMICAL PROPERTIES
Appearance and Odour
A light grey-white, free flowing powder.
Solubility in Water
Bulk Density
Solubility in Fat
Flash Point
Explosive Properties
Flammability
Combustibility
Boiling Point/Range
Oxidising Properties
Vapour Density
Evaporation Rate
Vapour Pressure
Partition Coefficient
Viscosity
Other Data
PERMETHRIN DUSTING POWDER
SDS No. 098
Issue : 06
27 : 10 : 2005
Page 2 of 4
STABILITY AND REACTIVITY
Conditions to avoid
Avoid extremes of temperature, e.g. below 0°C and above 40°C.
Materials to avoid
Hazardous Breakdown
In the event of fire, harmful and irritating fumes may be evolved.
Products
TOXICOLOGICAL INFORMATION (SEE ALSO BOX 2)
Acute Toxicity
For similar product: LD50 (rat) : >5,000 mg/kg.
High doses may cause repetitive activity in sensory and motor nerves. Early signs of exposureinclude nausea, vomiting, dyspnoea, hypernoea, tremors, general weakness and prostration. Ifdust is ingested product may be readily absorbed from the gastrointestinal tract.
Inhalation
For similar product: LC50 (rat) (4hr) : >2,3000 mg/L.
For similar product: LD50 (rabbit) : >30,000 mg/kg.
Corrosivity/
May cause transient irritation to skin.
Irritation
May cause transient irritation to eyes.
Respiratory
May cause transient irritation to the respiratory tract.
Sensitisation
Contains less than 1% skin sensitisers in the form of permethrin.
Respiratory
Contains no known respiratory sensitisers.
Repeat-Dose Toxicity
Product does not contain any components known to have any effects relating to repeated-dosetoxicity.
Mutagenicity
Product does not contain any components known to have a mutagenic effect.
Carcinogenicity
Product does not contain any components known to have a carcinogenic effect.
Reproductive
Fertility
Product does not contain any components known to have effects on fertility.
Toxicity
Development
Product does not contain any components known to be toxic to the reproductive system.
Other Information
ECOLOGICAL INFORMATION
General Information
This product is classified as very toxic to aquatic organisms and may cause long-term adverseeffects in the aquatic environment. However, when used in accordance with instructions given,controlled release of this product is not expected to cause environmental contamination.
Ecotoxicity Data
For permethrin:LC50 (Brown trout) (96h) : 0.0054 mg/LLC50 (Poecillia reticulata) (96h) : 0.0076 mg/LEC50 (Daphnia magna) (48h) : 0.00017 mg/L Mobility
Persistence and
For permethrin: >95% biodegradability in aqueous media: half life is ca. 5 days.
Degradability
Bioaccumulative Potential

Other Adverse Effects
DISPOSAL CONSIDERATIONS
Disposal of Waste /
Under normal circumstances, waste / empty containers will be disposed of by Rentokil Initial.
Containers
Classification

(Council Directive 91/689/EC,
Components making the waste hazardous Concentrations (%): Commission Decision 2000/532/EC
(amended) Commission Decision
2001/118/EC))
Note for Disposal

For further advice about disposal, in the UK, contact the local office of the Environment Agency(England and Wales) or Scottish Environment Protection Agency.
Local rate from anywhere in the UK: +44 (0) 870 850 6506.
PERMETHRIN DUSTING POWDER
SDS No. 098
Issue : 06
27 : 10 : 2005
Page 3 of 4
TRANSPORT INFORMATION (INTERNATIONAL UNLESS OTHERWISE INDICATED)
Tremcard
Reference No.
Transport Category
UK Hazchem EAC 2X
ADR HIN 90
(International Road)
Proper Shipping

ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID N.O.S (contains Limited Quantity
Maximum quantity per inner receptacle is 6 kg. Maximum quantity per outer package is Exemptions
Special Requirements Not required.
Packing Group III
IMDG 2004
IMDG EMS F-A, S-F
(Sea)
Proper Shipping

ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID N.O.S (contains Limited Quantity
Maximum quantity per inner receptacle is 5 kg. Maximum quantity per outer package is Exemptions
Special Requirements Not required.
Packing Group III
Note for Transport
Local, State or National requirements may apply to the carriage of this product.
REGULATORY INFORMATION (HEALTH AND SAFETY INFORMATION (SEE ALSO BOX 2))
Safety Phrases
This material and its container must be disposed of as hazardous waste.
Additional Label
Contains permethrin. May produce an allergic reaction.
To avoid risks to man and the environment, comply with instructions for use.
Legislation
Labelling is in accordance with UK regulations implementing the EC Directive 1999/45.
Additional labelling requirements may be necessary in accordance with other National legislation. Outside
the UK, the registration of this product may be necessary before use and any additional local
requirements must be observed at all times.
The information given on this Safety Data Sheet (SDS) does not constitute an assessment in
accordance with Control of Substances Hazardous to Health (COSHH) Regulations 2002, in the UK.
Other National measures or guidance should be sought where appropriate.
Information
Packaging Information Plastic lined 1 kg paper bags. Supplied in 5 x 1 kg packs.
Revisions
Changes have been made to the content of boxes 1, 2, 3, 4, 6, 7, 8, 9, 11, 12, 13, 14, 15 & 16 (asindicated by the thick lines on the left-hand side of the boxes) compared with issue 05.
Risk phrase text
: Harmful by inhalation and if swallowed.
: May cause sensitisation by skin contact.
: Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic PERMETHRIN DUSTING POWDER
SDS No. 098
Issue : 06
27 : 10 : 2005
Page 4 of 4
Before using any product, ensure that you read and understand its label.
The information contained in this safety data sheet is, to the best of our knowledge and belief, accurate and reliable at the time of publication. The
information relates only to the specific material designated in this safety data sheet and may not be valid for such material if it is used in combination
with any other material(s) or any other use than that specified herein. Rentokil Initial UK Ltd is not liable for the use of this product for any other
purpose than that described in this safety data sheet. This does not affect your statutory rights. It is the user’s responsibility to satisfy him/herself as
to the suitability in completeness of such information for his/her own particular use.
Copyright (2005) Rentokil Initial plc, R&D, Felcourt, East Grinstead, West Sussex. RH19 2JY. United Kingdom.
Telephone: +44 (0) 1342 833022 Fax: +44 (0) 1342 326229 Web

Source: http://www.rentokil.co.uk/files/file_212747.pdf

Anmeldebogen für katheter

HERZZENTRUM SAAR Medizinische Kardiologie Hkt-Nr: __________________ Chefarzt: Dr. med. Cem Özbek 66333 Völklingen, Richardstr. 5-9 Datum: __________________ Tel: 06898 / 12 2476 Mo-Fr: 8:3o - 16:3o HERZKATHETERLABOR ANMELDEBOGEN Personalien: Befundberichte an: Hausarzt: Station: INDIKATION O KHK / V.a. KHK ( weiter bei 1 ) O Z.n. Bypass-OP ( wei

Microsoft word - 46b92cac-328d-28c88e.doc

Methylphenidate and Dextroamphetamine Abuse Methylphenidate and Dextroamphetamine Abuse in Substance-Abusing Robert J. Williams, PhD1; Leslie A. Goodale, RN2; Michele A. Shay-Fiddler, MSW2; Susan P. Gloster, BN3; Samuel Y. Chang, MD2 1. Addiction Counselling Program; School of Health Sciences; University of Lethbridge 2. Addiction Centre; Foothills Medical Centre; Calgary, Alberta 3. Lethbri

Copyright © 2009-2018 Drugs Today